• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估计算机模拟人源化对 VH 动力学的潜在影响。

Evaluation of the Potential Impact of In Silico Humanization on VH Dynamics.

机构信息

Université Paris Cité and Université de la Réunion and Université des Antilles, INSERM, BIGR, DSIMB, F-75014 Paris, France.

Université Paris Cité and Université de la Réunion and Université des Antilles, INSERM, BIGR, DSIMB, F-97715 Saint Denis Messag, France.

出版信息

Int J Mol Sci. 2023 Sep 26;24(19):14586. doi: 10.3390/ijms241914586.

DOI:10.3390/ijms241914586
PMID:37834033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10572902/
Abstract

Camelids have the peculiarity of having classical antibodies composed of heavy and light chains as well as single-chain antibodies. They have lost their light chains and one heavy-chain domain. This evolutionary feature means that their terminal heavy-chain domain, VH, called VH here, has no partner and forms an independent domain. The VH is small and easy to express alone; it retains thermodynamic and interaction properties. Consequently, VHs have garnered significant interest from both biotechnological and pharmaceutical perspectives. However, due to their origin in , they cannot be used directly on humans. A humanization step is needed before a possible use. However, changes, even in the constant parts of the antibodies, can lead to a loss of quality. A dedicated tool, Llamanade, has recently been made available to the scientific community. In a previous paper, we already showed the different types of VH dynamics. Here, we have selected a representative VH and tested two humanization hypotheses to accurately assess the potential impact of these changes. This example shows that despite the non-negligible change (1/10th of residues) brought about by humanization, the effect is not drastic, and the humanized VH retains conformational properties quite similar to those of the camelid VH.

摘要

骆驼科动物具有独特的特性,其经典抗体由重链和轻链以及单链抗体组成。它们已经失去了轻链和一个重链结构域。这种进化特征意味着它们的末端重链结构域 VH(这里称为 VH)没有伴侣,形成一个独立的结构域。VH 很小,易于单独表达;它保留了热力学和相互作用特性。因此,VH 引起了生物技术和制药领域的极大兴趣。然而,由于它们起源于骆驼科动物,因此不能直接用于人类。在可能使用之前,需要进行人源化步骤。然而,即使在抗体的恒定部分发生变化,也可能导致质量损失。最近,一种名为 Llamanade 的专用工具已提供给科学界。在之前的一篇论文中,我们已经展示了不同类型的 VH 动力学。在这里,我们选择了一个代表性的 VH,并测试了两种人源化假设,以准确评估这些变化的潜在影响。这个例子表明,尽管人源化带来了不可忽视的变化(1/10 个残基),但影响并不剧烈,人源化的 VH 保留了与骆驼科 VH 相当相似的构象特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/179d9d770148/ijms-24-14586-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/730ffa1ae153/ijms-24-14586-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/8103993703e5/ijms-24-14586-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/d7bfd4bce567/ijms-24-14586-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/02ff0d4684dc/ijms-24-14586-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/371e974a13a6/ijms-24-14586-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/179d9d770148/ijms-24-14586-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/730ffa1ae153/ijms-24-14586-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/8103993703e5/ijms-24-14586-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/d7bfd4bce567/ijms-24-14586-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/02ff0d4684dc/ijms-24-14586-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/371e974a13a6/ijms-24-14586-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c4/10572902/179d9d770148/ijms-24-14586-g006.jpg

相似文献

1
Evaluation of the Potential Impact of In Silico Humanization on VH Dynamics.评估计算机模拟人源化对 VH 动力学的潜在影响。
Int J Mol Sci. 2023 Sep 26;24(19):14586. doi: 10.3390/ijms241914586.
2
Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama.羊驼无抗原重链可变区(VHH)的溶液结构和主链动力学
Proteins. 2002 Jun 1;47(4):546-55. doi: 10.1002/prot.10096.
3
Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features.羊驼重链V区由至少四个不同的亚家族组成,揭示了新的序列特征。
Mol Immunol. 2000 Aug;37(10):579-90. doi: 10.1016/s0161-5890(00)00081-x.
4
VH Structural Modelling Approaches: A Critical Review.VH 结构建模方法:批判性评价。
Int J Mol Sci. 2022 Mar 28;23(7):3721. doi: 10.3390/ijms23073721.
5
Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology.与猪胰α-淀粉酶复合的三个骆驼科VHH结构域。结合拓扑结构的抑制作用和多功能性。
J Biol Chem. 2002 Jun 28;277(26):23645-50. doi: 10.1074/jbc.M202327200. Epub 2002 Apr 17.
6
Nanobodies: natural single-domain antibodies.纳米抗体:天然单域抗体。
Annu Rev Biochem. 2013;82:775-97. doi: 10.1146/annurev-biochem-063011-092449. Epub 2013 Mar 13.
7
Global analysis of VHHs framework regions with a structural alphabet.使用结构字母对VHH框架区域进行全局分析。
Biochimie. 2016 Dec;131:11-19. doi: 10.1016/j.biochi.2016.09.005. Epub 2016 Sep 6.
8
General Trends of the Antibody VHs Domain Dynamics.抗体 VH 结构域动力学的总体趋势。
Int J Mol Sci. 2023 Feb 24;24(5):4511. doi: 10.3390/ijms24054511.
9
Antibody repertoire development in camelids.骆驼科动物抗体库的发育
Dev Comp Immunol. 2006;30(1-2):187-98. doi: 10.1016/j.dci.2005.06.010.
10
Introduction to heavy chain antibodies and derived Nanobodies.重链抗体及衍生纳米抗体简介。
Methods Mol Biol. 2012;911:15-26. doi: 10.1007/978-1-61779-968-6_2.

引用本文的文献

1
A Simple Analysis of the Second (Extra) Disulfide Bridge of VHs.VH 区中二硫键(额外)的简单分析。
Molecules. 2024 Oct 14;29(20):4863. doi: 10.3390/molecules29204863.

本文引用的文献

1
Ozoralizumab: first Nanobody® therapeutic for rheumatoid arthritis.奥扎鲁单抗:首个用于类风湿关节炎的纳米抗体治疗药物。
Expert Opin Biol Ther. 2023 Jul-Dec;23(7):579-587. doi: 10.1080/14712598.2023.2231344. Epub 2023 Jul 11.
2
Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies.纳米抗体鉴定的 SARS-CoV-2 受体结合域(RBD)中和与增强表位。
Viruses. 2023 May 26;15(6):1252. doi: 10.3390/v15061252.
3
NbThermo: a new thermostability database for nanobodies.NbThermo:一个新的纳米抗体热稳定性数据库。
Database (Oxford). 2023 Apr 12;2023. doi: 10.1093/database/baad021.
4
NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.NANOBODIES®:诊断和治疗应用的综述。
Int J Mol Sci. 2023 Mar 22;24(6):5994. doi: 10.3390/ijms24065994.
5
Structural and Dynamic Differences between Calreticulin Mutants Associated with Essential Thrombocythemia.与原发性血小板增多症相关的钙网织蛋白突变体的结构和动态差异。
Biomolecules. 2023 Mar 10;13(3):509. doi: 10.3390/biom13030509.
6
General Trends of the Antibody VHs Domain Dynamics.抗体 VH 结构域动力学的总体趋势。
Int J Mol Sci. 2023 Feb 24;24(5):4511. doi: 10.3390/ijms24054511.
7
Quality assessment of VH models.VH模型的质量评估。
J Biomol Struct Dyn. 2023;41(22):13287-13301. doi: 10.1080/07391102.2023.2172613. Epub 2023 Feb 8.
8
Ozoralizumab: First Approval.奥佐利珠单抗:首次获批。
Drugs. 2023 Jan;83(1):87-92. doi: 10.1007/s40265-022-01821-0.
9
NanoNet: Rapid and accurate end-to-end nanobody modeling by deep learning.NanoNet:通过深度学习实现快速准确的全流程纳米抗体建模。
Front Immunol. 2022 Aug 12;13:958584. doi: 10.3389/fimmu.2022.958584. eCollection 2022.
10
Phase II/III Results of a Trial of Anti-Tumor Necrosis Factor Multivalent NANOBODY Compound Ozoralizumab in Patients With Rheumatoid Arthritis.抗肿瘤坏死因子多价纳米体复合物奥扎鲁单抗治疗类风湿关节炎患者的 II/III 期试验结果。
Arthritis Rheumatol. 2022 Nov;74(11):1776-1785. doi: 10.1002/art.42273. Epub 2022 Oct 3.